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Abstract: Aminobisphosphonates, e.g., alendronate and neridronate, are a well known 
class of molecules used as drugs for various bone diseases. Although these molecules  
have been available for decades, a detailed understanding of their most important 
physicochemical properties under comparable conditions is lacking. In this study, ten 
aminobisphosphonates, H2N(CH2)nC(OH)[P(O)(OH)2]2, in which n = 2–5, 7–11 and 15 
have been synthesized. Their aqueous solubility as a function of temperature and pH,  
pKa-values, thermal stability, IR absorptions, and NMR spectral data for both liquid  
(1H, 13C, 31P-NMR) and solid state (13C, 15N and 31P-CPMAS NMR) were determined. 
Keywords: bisphosphonates; aqueous solubility; pKa; physicochemical properties 
 
1. Introduction 
Bisphosphonates (BPs), characterized by the presence of the P-C-P backbone, are stable analogues 
of naturally occurring pyrophosphate. The BPs were first synthesized about 150 years ago [1], but the 
golden age of these molecules started approximately 50 years ago [2]. Initially BPs were used as water 
softeners and in prevention of scaling, but their current therapeutic use stems from their high affinity 
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for the bone mineral hydroxyapatite. In the clinic, BPs are mainly used for treatment of different bone 
diseases and calcium metabolism disorders [3,4], but they are also effective as bone imaging agents 
when linked to a gamma-emitting technetium isotope. They can also be bone-targeting promoieties, 
e.g., for anti-inflammatory drugs [5], as solvent extraction reagents for actinide ions [6] and are even 
present in a new class of herbicides [7]. Recently, BPs have been used as growth inhibitors for 
parasitic diseases like malaria [8] and in crystal engineering studies [9]. BPs have been also reported to 
be effective inhibitors of atherosclerosis [10] and nitrogen-containing BPs have been shown to be 
effective antitumor agents [11]. 
The medical use BPs can be divided into two categories, non-nitrogen-containing (NNBP) and 
nitrogen-containing (NBP) molecules, based on their different mechanism of action in living  
systems [12]. The NNBP compounds (e.g., etidronate, clodronate) lack a nitrogen atom at the bridging 
carbon substituents, whereas NBP compounds (e.g., pamidronate, alendronate and zoledronate) have at 
least one nitrogen atom incorporated at the bridging carbon side-chains. Moreover, BPs are also 
classified based on their potency in different generations. Typical examples of 1st generation BPs are 
the NNBP compounds mentioned above. NBP compounds with sp3 nitrogen as a part of alkyl  
side-chain are called 2nd generation compounds while the 3rd generation NBP compounds are those 
molecules in which the sp2 nitrogen is a part of a heterocyclic ring. The studied compounds here 
belong to the 2nd generation BPs. 
Our group has studied BP compounds for more than 20 years. Recently, we became interested in 
preparing a series of aminobisphosphonates (ABPs) with variable chain lengths (n = 2–15), since it 
was obvious that the chain length could influence the solubility, i.e., pamidronate (1) was almost freely 
soluble in water whereas a compound with a longer chain, e.g., n = 10, was virtually insoluble in water 
and most common organic solvents. Moreover, although pamidronate (1), alendronate (2) and 
neridronate (4) are in drug use and they have been intensively studied by several groups, there is still some 
discrepant information, concerning their properties, e.g., there are variations in their pKa values published 
in the literature [13–19]. 
In this work, we describe the syntheses of the ten ABPs shown in Figure 1. Their aqueous 
solubilities and pKa-values as a function of carbon chain length were determined. The compounds 
were also characterized by IR and NMR spectroscopic methods. NMR spectra were recorded both for 
liquid (1H, 13C, 31P-NMR) and solid state samples (13C, 15N and 31P-NMR). Elemental analyses were 
measured determine out the number of water molecules (hydrates) in the samples and this data was 
confirmed with thermal analysis. We also attempted to measure accurate logP values (−1 to −4) with 
the conventional water-octanol system, but the solubility of ABPs in the octanol phase was minimal 
and it was thus difficult to obtain accurate reproducible values. 
Figure 1. Structures of studied aminobisphosphonates. 
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2. Results and Discussion 
2.1. Solubility of the ABPs  
The studied compounds 1–10 were prepared according to the general method reported by 
Kieczykowski et al. [20]. All the compounds were readily obtained with >98% purity after 
crystallization from ethanol, water or a mixture of ethanol and water. Yields were typically between 
75–100%, except for pamidronic acid (1) which was crystallized as a monosodium salt in 22% yield. 
Preparation of the compound with n = 6 was not successful using this method and the starting 
materials needed for compounds in which n = 12–14 were rather expensive and therefore not used. 
Determination of the exact molecular composition (formula) was the key to determining the 
physicochemical data for the studied compounds exactly, since based on the earlier studies, e.g., for 
different clodronic acid derivatives [21] it is known that BPs may crystallize as hydrates containing up 
to five molecules of water. The number of water molecules in the studied compounds were measured 
using the traditional elemental analysis technique and the results were verified by thermal 
decomposition analysis. Table 1 provides the formulas of the amino(CH2)nbisphosphonates, their pH’s 
at saturated solution, and aqueous solubilities at 21 °C. However, only compounds 6 and 8 contained 
one water molecule each, even though the compounds were stored for days in an open vial. 
Table 1. Prepared aminobisphosphonates with the formula determined from elemental 
analysis, the pH of their saturated solutions, and the aqueous solubilities at 21 °C (agitation 
time 30 min). 
Compound n Formula MW pH 
Solubility 
(mg P/L) a (mgL) b 
1 2 C3H10NO7P2Na 257.05 4.62 2634 10928 
2 3 C4H13NO7P2 249.10 1.94 1905 7663 
3 4 C5H15NO7P2 263.12 2.22 944 4009 
4 5 C6H17NO7P2 277.15 2.26 764 3419 
5 7 C8H21NO7P2 305.20 2.61 426 2099 
6 8 C9H23NO7P2 · H2O 337.23 2.51 400 2066 
7 9 C10H25NO7P2 333.26 3.28 40 217 
8 10 C11H27NO7P2 · H2O 365.30 4.71 10 58 
9 11 C12H29NO7P2 361.31 4.05 5 30 
10 15 C16H37NO7P2 417.42 7.79 6 39 
a phosphorus concentration in saturated solution; b compound solubility. 
The accurate determination of solubility for the compounds here is demanding since the solubility is 
dependent on several factors, such as crystal size, stirring efficiency and stirring time. The values 
stated in Table 1 are good estimates for solubility, since the values in the table were measured under 
comparable conditions (temperature, stirring speed and time) for all the compounds, which were 
prepared and crystallized using the same protocol. However, compound 1 was crystallized as a 
monosodium salt which presumably made it more soluble than it would have been in the acidic form. 
The solubility for the studied compounds here are somewhat less than the solubility measured as a 
function of temperature using different agitation times of 30 min and 24 h, respectively. In general, in 
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terms of water solubility, the studied compounds can be classified into three groups depending on the 
chain length: compounds 1–6 are soluble in gram quantities, compound 7 in quantities of hundreds of 
milligrams and the remaining compounds in tens of milligrams per liter (Figure S1). Most probably the 
reason for the poor solubility of the compounds with the longer carbon chains (n > 7) is increased 
hydrophobicity and carbon chain van der Waals forces that overcome hydrogen bonding forces 
between water and the heteroatoms in the ABPs. 
The effect of temperature on solubility was also studied for compounds 2, 4 and 5 at 4.0 °C, 7.6 °C, 
21.0 °C, 30.0 °C, 40.0 °C and 50.0 °C (Table S1). As expected, the solubility increased when the 
temperature was increased as shown in Figure 2. Interestingly, solubility was increased markedly for 
compounds 2 and 4 after 30 °C but for compound 5 the same effect was observed after 40.0 °C. In 
general, the solubility for the compounds was almost doubled, when the temperature was increased to 
about 40.0 °C, in the temperature transition from 7.6 °C to 50.0 °C.  
Figure 2. The effect of temperature on the aqueous solubility (mg/L) of ABPs 2, 4 and 5 
(agitation time 30 min). 
 
As is shown in Figure 3, the effect of pH from 0.5 to 11.0 on solubility was studied for compounds 
2, 4, 6, 8 and 9 (Table S2). Interestingly, pH had no major influence on the solubility of compounds 2, 
4 and 6 and only at very low pH (pH 0.5), were the solubilities doubled as compared to the values at 
pH 1. Instead, compounds 8 and 9 which had low solubilities displayed a clear solubility minimum at 
about pH 2 with the values increasing at both low and elevated pH’s. 
2.2. Protonation Constants for Compounds 1–5 
The analysis of the data was initiated by plotting ZH versus pH [see Equation (3) and Figure S2 in 
the Supporting Information]. The neutralization titrations show that the stepwise deprotonation of H5L+ 
to H3L− occurred in a very acidic pH range from values less than 1 to about 3 (ZH from 3 to 1). H3L− is 
the major species from pH 3 to pH 5 when ZH = 1. H2L2− is the major species from pH 7 to pH 10 
when ZH = 0 (three phosphonic acid groups). The negative ZH values that were obtained in the pH 
range from 10 to over 12 reveal that in alkaline solution, one proton can leave the ligands from the last 
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phosphonic acid group, H2L2− to HL3−, and finally from the amino group, HL3− to L4−. In Figure S2 in 
the Supporting Information, the symbols show the measured values and solid lines are the ZH curves 
calculated from log β values.  
Figure 3. The effect of pH on the aqueous solubility (mg/L) of BP (a) 2, 4 and 6; (b) 8 and 
9 (agitation time 30 min).  
 
Results were obtained from SUPERQUAD as overall stability constants (log β values); following 
the chosen zero level H2L2−. This zero level H2L2− was chosen in the calculations to avoid any 
accumulation of errors of protonation constants at different pH ranges. The log β results for reactions 
(4) and (5) obtained in the final refinements are listed in Table S3 (see Supporting Information) with 
error limits (±3σ), number of points/number of titrations and χ2/Σ statistics. All results for compounds 
1, 2, 3, 4, and 5 were recalculated for the stepwise protonation constants, log K (or pKa) values, see 
Table 2. Although the values of the last protonation constants (pKa1 values) could be calculated from 
the experimental data, they should only be considered as approximate values. This is reflected also in 
the larger error limits for these constants as compared to the other constants.  
The logK values for compounds 1, 2 and 4 from earlier studies can be found in literature, but they 
are not entirely comparable with each other because of the different experimental conditions  
used (e.g., background electrolyte, ionic strength, temperature or method) [13–19]. Although these 
values vary to some extent for each ligand, they do agree with each other on the whole, taking into 
consideration the different conditions. Furthermore, the results of this study correspond well to the 
literature values for compounds 1, 2 and 4. A detailed comparison of literature pKa values is given in 
Tables 3 and 4. 
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Table 2. The stepwise protonation of compounds 1, 2, 3, 4, and 5 in this study. 
Protonation 
Reaction 
log K 
pKa 
1 2 3 4 5 
L4− + H+ ⇋ HL3− 12.86 a 12.13 f 12.05 11.94 k 11.65 pKa5 
HL3− + H+ ⇋ H2L2− 10.04 b 10.69 g 10.78 10.86 l 10.67 pKa4 
H2L2− + H+ ⇋ H3L− 5.90 c 6.26 h 6.44  6.62 m 6.75 pKa3 
H3L− + H+ ⇋ H4L 1.70 d 2.12 i 2.30 2.38 n 2.52 pKa2 
H4L + H+ ⇋ H5L+ 1.06 e 0.60 j 0.62 0.94 1.08 pKa1 
Variations in the pKa values in the literature for compounds 1, 2 and 4: a 13.06–10.40; b 10.30–9.46;  
c 6.04–5.39; d 2.56–1.80; e 1.24 or lower; f 12.68–10.5; g 11.07–10.25; h 8.73–5.95; i 2.72–2.16;  
j 1.33 or lower; k 10.9; l 10.66–8.63; m 6.50–5.49; n 2.90–2.45. 
The following general trend can be found in the results of this study: the lengthening of the CH2 
chain between BP and amino groups decreases the value of the first protonation constant (pKa5, amino 
group) and increases the values of the other protonation constants (phosphonate groups) in most cases 
(Table 2). The same trend can be seen also in those earlier studies where a comparison is possible, e.g., 
for all pKa values with compounds 1 and 2 [14,17] and for pKa values of the phosphonate groups with 
compounds 1 and 2 [13,18] and with compounds 1 and 4 [16]. The protonation of the ligands is also 
illustrated in the percentage distribution curves calculated from log β values (see Figure S3 in the 
Supporting Information). 
Table 3. The stepwise protonation of compound 1 in the literature [4,13–18]. 
Protonation 
Reaction 
compound 1 logK 
pKa 
Ref.13 Ref.14 Ref.15 Ref.4 Ref.17 Ref.18 Ref.18 
L4− + H+ ⇋ HL3− 10.8 13.06 10.95 11.02 12.14 10.74 10.40 pKa5 
HL3– + H+ ⇋ H2L2− 9.9 10.30 9.80 9.90 10.18 9.97 9.46 pKa4 
H2L2− + H+ ⇋ H3L− 5.83 5.85 6.01 5.86 6.04 6.01 5.39 pKa3 
H3L− + H+ ⇋ H4L 2.55 1.80 2.56 2.04 1.93 - - pKa2 
H4L + H+ ⇋ H5L+ - <1.2 - - 1.24 - - pKa1 
Table 4. The stepwise protonation of compounds 2 and 4 in the literature [4,13,14,17–19]. 
Protonation 
Reaction 
Comp. 2 logK Comp. 4 logK 
pKa 
Ref.13 Ref.14 Ref.17 Ref.18 Ref.18 Ref.19 Ref.13 Ref.4 
L4− + H+ ⇋ HL3− 11.6 12.68 11.82 11.4 10.5 12.04 10.9 - pKa5 
HL3− + H+ ⇋ H2L2− 10.5 11.07 10.96 10.68 10.25 10.77 8.63 10.66 pKa4 
H2L2− + H+ ⇋ H3L− 8.73 6.36 6.39  6.38 5.95 6.21 5.49 6.50 pKa3 
H3L− + H+ ⇋ H4L 2.72 2.19 2.22 2.24 2.34 2.16 2.90 2.45 pKa2 
H4L + H+ ⇋ H5L+ - <1.2 1.33 - - ~1 - - pKa1 
The pKa values were also determined for compounds 1–5 using the Sirius instrument. This 
comparison was done since this instrument is commonly used for the determination of pKa values in 
many laboratories and we wanted to study the accuracy and reliability of this automatic system. In 
general, in our hands the Sirius instrument was not able to measure the first pKa1 values near to 1, but 
rather reliable values for pKa2 and pKa3 values were observed for all studied compounds. In addition, 
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for compounds 1 and 2, the remaining pKa values were consistent with the values shown in Table 2, 
but for compounds 3–5 clear differences were observed. Detailed results are shown in the Supporting 
Information (Table S4). 
2.3. NMR Spectroscopy  
1H, 13C and 31P-NMR spectroscopy are the best methods with which to analyze the chemical 
composition of BPs in liquid and solid states. However, liquid state NMR is more common and solid 
state measurements are typically used for poorly soluble compounds. The 13C and 31P-NMR chemical 
shift data both in liquid and solid states including also the solid state 15N-NMR chemical shifts for the 
studied compounds are given in Table S5 in the Supporting Information. Detailed 1H-NMR data is also 
given in the Supporting Information. 
The 13C-NMR signals for the studied ABPs were easily assigned when starting from the bridging 
carbon resonance, which appeared as a characteristic triplet at approx. 79 ppm and 72–75 ppm in 
liquid and solid state spectra, respectively, due to the presence of deshielding OH group and the 
coupling to two phosphorus atoms. C-3 also appeared as a triplet (3JCP ca. 5 Hz) in the liquid state and 
C-2 was clearly broadened (2JCP < 1 Hz) as compared to other carbon signals due to phosphorous 
coupling. The assignment of carbon next to the amino group (CH2-N) was also straight forward and its 
shift varied from 41 to 45 and 38 to 42 ppm in liquid and solid state spectra, respectively. The rest of the 
chemical shifts were as expected, but it was impossible to assign the chemical shifts for compounds 6–10 
in the solid state due to overlapping shifts and polymorphism which broadened the observed signals. 
15N-CPMAS chemical shifts are typical for primary amines and do not vary extensively (Table S5). 
All liquid state 31P-NMR signals are also approx. at 19 ppm, this being a typical value for BP 
compounds. However, in the solid state 31P-NMR spectra, two signals for each compound were 
observed, since in the crystalline state the phosphorous atoms are always located in an unequal 
chemical environment. The 31P-NMR chemical shifts for acids 2–4 (compound 1 is monosodium salt) 
were also clearly different compared to acids 5–10 indicating that these groups have different crystal 
structures from each other.  
A detailed analysis of 1H-NMR spectra for the studied compounds without iterative computerized 
methods is impossible, since the spin systems in compounds like these are more complicated than 
expected because of prochirality. It is commonly claimed in the literature that, for certain BPs, e.g., 
alendronate, the N-CH2-CH2-CH2-C(OH)P2 gives rise to a first order spin system, in which NCH2 
group exists as a triplet (t), the middle CH2 as a quintet and the CH2-C group as t+t (last triplet due to 
phosphorous coupling). However, as shown in Figure 4, only the NCH2 group appears as a first order 
triplet with expected 1:2:1 intensities and the rest of CH2 groups give rise to a complicated multiplet. 
In fact, the R-CH2-C(OH)P2 fragment is a typical example of prochiral systems, in which CH2 protons 
become magnetically non-equivalent, forming an AB-spin system and they likely have different chemical 
shifts and coupling constants [22]. The same is true at least for the protons at the next CH2 group. 
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Figure 4. Observed (bottom) and calculated (upper) 1H-NMR spectrum of alendronic acid. 
 
The results from computerized analysis are given in Table 5 for compounds 1–5. A detailed analysis 
for the rest of the compounds was not realistic due to the broad signals and heavily overlapping peaks. 
Moreover, the values given in Table 5 are only good estimates for the coupling constants present in the 
studied molecules, since the spectral lines were rather broad (W1/2 = 1–1.5 Hz) due intra- and 
intermolecular hydrogen bonding. Iterative analysis showed clearly that CH2 protons had the same 
chemical shift, since geminal 2JHH coupling was missing, but different vicinal 3JHH coupling constants 
existed. 3JHP coupling constants were taken from coupled 31P-NMR spectra and 4JHP coupling 
constants were obtained from spectral analysis. 
Table 5. 1H-NMR chemical shifts and coupling constant for compounds 1–5. 
  H-2a H-2b H-3a H-3b H-4 H-5 H-6 
1 shift (ppm) 
3JHH (Hz) 
3/4JHP (Hz) 
2.04  
9.8, 5.8  
13.4 
2.04  
10.0, 5.7  
13.4 
2.94  
10.0, 5.8 
0.9 
2.94  
9.8, 5.7  
0.9 
   
2 
 
shift (ppm) 
3JHH (Hz) 
3/4JHP (Hz) 
1.87  
13.9, 4.4 
13.5 
1.87  
11.7, 4.2 
13.5 
1.73  
11.7, 8.8, 4.4  
1.0 
1.73  
13.9, 5.4, 4.2 
1.0 
2.59  
8.8, 5.4 
- 
  
3 
 
shift (ppm) 
3JHH (Hz) 
3/4JHP (Hz) 
1.88  
13.9, 5.6 1 
13.6 
1.88  
11.8, 2.9 
13.6 
1,62  
13.9, 5.9, 2.9 
1.0 
1.62  
11.8, 9.4, 5.6  
1.0 
1.47  
9.4, 6.9, 5.9  
- 
2.70  
6.9 
- 
 
4 
 
shift (ppm) 
3JHH (Hz) 
3/4JHP (Hz) 
1.88  
12.4, 4.0  
13.3 
1.88  
13.4, 4.5 
13.3 
1.58  
13.4, 7.2, 4.0 
0.9 
1.58  
12.4, 7.9, 4.5  
0.9 
1.29  
7.9, 7.8, 7.2 
- 
1.47  
7.8, 7.1 
- 
2.61  
7.1 
- 
5 
 
shift (ppm) 
3JHH (Hz) 
3/4JHP (Hz) 
1.87  
13.0, 4.3 
13.3 
1.87  
13.0, 4.3 
13.6 
1.56  
13.0, 6.0, 4.3  
1.5 
1.56  
13.0, 7.7, 4.3 
1.5 
2 2 1.46  
7.1, 6.7 
- 
1 4J2a4 = 1.9 Hz 2 H-4 and H-5 signals not analyzed due to the presence of heavily overlapping 
signals, H-7: 2.62 ppm, 3JHH = 7.1 Hz. 
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The results clearly indicate that the R and C(OH)P2 groups are almost entirely trans to each other in 
the R-CH2-CH2-C(OH)P2 part of the molecule containing three or more CH2 units between the amino 
and C(OH)P2 moieties, since both CH2 protons have one large trans (>11 Hz) and one gauche (4–6 Hz) 
coupling. In the case of pamidronate, coupling constants are about 6 and 10 Hz indicating that the 
amount of the trans conformation is diminished due to intramolecular hydrogen bonding and zwitter 
ion interaction between amino and phosphorous groups. 
2.4. Thermal Analysis 
Despite the fact that alkylaminobis(phosphonates) are a group of substances that have been widely 
investigated and are medically used substances, according to the literature, their thermoanalytical 
properties have been rarely determined in a comprehensive manner. In this study, thermoanalytical 
methods were utilized, in order to evaluate the thermal stability and potential hydrate stoichiometry of 
the examined compounds. Moreover, thermogravimetric studies were performed in parallel using two 
instruments with slightly different sample crucibles (tall and a shallow vessel), in order to evaluate the 
influence of “micro-atmospheric effects” that may prevail during heating inside the different crucibles 
used in the measurements. 
For compounds which have a primary amine and an acidic phosphonate group in the same 
molecule, this enables the formation of zwitterions, at least for compounds having shorter alkylidene 
chains between the terminal groups. Indeed a few X-ray crystallographic studies have been  
conducted to reveal the inner salt nature of pamidronic (1-hydroxypropylidene chain) alendronic  
(1-hydroxybutylidene) and neridronic (1-hydroxyhexylidene) acids [23–25]. A similar zwitterionic 
behavior is generally observed also in aliphatic amino acids, the decomposition of which is typically 
initiated either via deamination or decarboxylation reaction, of which the latter is the more favored 
route among this type of amino acids [26]. With alkylaminobis(phosphonates), it is anticipated that the 
decomposition may more likely commence via deamination instead of a dephosphonation reaction due 
to the more stable nature of the phosphonate group. One also has to take into account the fact that 
special care must be taken in evaluating the potentiality of water molecules in these types of 
compounds, because the weight loss difference between cleavage of ammonia and one water crystal is 
nearly always the same for substances having formula weights around 300 g/mol as in this case. 
Therefore, a truly anhydrous substance can easily be misinterpreted as being a hydrate and vice versa 
when the analysis of the evolved gas components is not available. Therefore, it is crucial to apply in 
parallel to TGA, other characterization techniques as well. In this study, elemental analysis (see 
preceding sections), visual inspection in the melting apparatus and structural studies by X-ray powder 
diffraction were applied. It is noted that the successful powder structure determination of compounds 3 
and 5 will be published elsewhere as they were not within the scope of this study. 
The experimental and calculated wt-%, together with the temperature range of dehydration, 
decomposition onsets and estimated melting points (from DTA signal) can all be seen in Table 6 and 
the measured TG curves are given in the Supporting Information. The ABPs 1–5 with shorter  
1-hydroxyalkylidene chains (varying from 2 to 7 carbons) all exhibited a weight loss of about 4–7 wt-% 
on a first step with temperature onsets varying from about 150 to 230 C. It might seem that weight 
losses are in good agreement with the calculated cleavage values of one water of crystallization 
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molecule present in each compound. However, as evidenced by visual monitoring in the melting point 
apparatus, elemental analyses, and by X-ray powder diffraction analyses all five compounds proved to 
be free of water of crystallization. Consequently, the first decomposition process for these compounds 
is in good agreement with the proposal that it is due to the cleavage of an amino group as NH3  
(e.g., for compound 2 (exp. 7.02% calc. 6.84%; see detailed values for each compound in the 
Supporting information Table S6). The second decomposition step of 2–5 readily followed the first 
step and this is assumed to be due to the release of water (e.g., for 2 exp. 7.49% calc. 7.23%) which 
most likely originates from the cleavage of the hydroxyl group attached to C1-carbon. For 2–5, the 
major degradation reactions commence in a compound-specific manner above 250–300 °C with 
breakage of the C-P bond that leads to further pyrolysis of the samples [27]. It can be noted that overall 
the shorter alkyl chain compounds display somewhat lower decomposition temperatures than the 
longer alkyl chain versions (Table 6). In case of compound 1 (monosodium salt), the decomposition 
deviates slightly from the acids 2–5, as after the cleavage of the amino group between 100–200 C, the 
subsequent larger weight loss (~14.2 wt-%) includes most likely the cleavage of the hydroxyl group as 
in 2–5 but concurrently, a more comprehensive degradation of the compound occurs in the temperature 
range of 200–300 °C. This large weight loss step is followed by a further pyrolysis of the product at a 
temperature above 300 °C. In addition, the higher residual weight at 700 °C is indicative of the 
formation of inorganic thermally stable Na-containing salt(s) together with charring. In an attempt to 
identify the black residue, X-ray powder diffraction data was evaluated, and as a result, sharp 
diffraction peaks characteristic for disodium diphosphate (Na2H2P2O7) were identified in the pattern 
along with broad scattering humps caused by the amorphous carbonized content (Supporting 
Information, Figure S4). 
Table 6. Thermal properties of compounds 110. 
Comp. MW  
wt-% (%) Temp. 
range b Tm 
c Td d 
Ref. melting 
points exp. calc. 
1 257.05 anhydrous  149 152 - 
2 249.10 anhydrous  223 224 234 (dec.) f 
3 263.12 anhydrous  216 220 212 (dec.) f 
4 277.15 anhydrous  205 212 247 f 
5 305.20 anhydrous  193 195 - 
6 337.23 a 5.00 5.34 (1 H2O) 33–175 (81) 134 191 - 
7 333.26 anhydrous  181 187 - 
8 365.30 a 4.43 4.93 (1 H2O) 40–148 (72) 127 202 - 
9 361.31 anhydrous  181 188 - 
10 417.42 anhydrous  175 180 - 
a MW of hydrate; b temperature range of dehydration (onset T in parentheses); c from DTA signal of 
TG/DTA (decomposition coexists with melting on all compounds); d onset values; All temperatures 
are in °C and the Td results are shown as an average from both instruments. Values from the 
individual devices can be found in Supporting Information (Table S6); f see reference [28]. 
For compounds 6–10 with long alkyl chains, visual monitoring and the elemental analysis results 
indicate that only 6 and 8 are monohydrates (exp. 5.00 and 4.33 wt-% calc. 5.34 and 4.93 wt-%, 
respectively), whereas the others exist in an anhydrous form. For compounds 7, 9 and 10 the first 
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weight loss step observed in the thermograms points to cleavage of the amino group, which occurs 
typically at about 200 C, whereas the dehydration of compounds 6 and 8 occurs at significantly lower 
temperatures. In compound 6, dehydration is initiated at ~90 C and this is readily followed by the 
cleavage of the amino group. Compound 8 exhibits a similar dehydration sequence with the exception 
that the deamination is initiated at the higher temperature of 200 C (Table 6). The major 
decomposition stage (after cleavage of amino group) of these longer alkyl chained bisphosphonates 
occurs quite uniformly above 350 °C. 
The influence of sample crucible was clearly evidenced in the TG analyses performed as somewhat 
different TG curve trends were observed at higher temperature ranges for all samples. As expected, the 
higher crucible used in TG/DTA seems to generate a less oxidizing environment above the sample 
surface. This is clearly visible in the measured TG curves as the residual weights (Figure S5) at the end 
the temperatures were always higher in the TG/DTA in contrast to the measurements made with TGA 
7, and a shallower sample crucible (Table 6). Therefore, this suggests that there is a higher degree of 
charring of the samples in the case of the TG/DTA instrument. This was also noted visually. Although 
conditions seemed to be less oxidizing in the higher crucible, all samples degraded at a higher rate 
within the temperature range of ~350 to 550 °C, in contrast to the situation if the samples were heated 
in the shallow crucible (Figure S5). It can be assumed that somewhat better oxidation conditions were 
present in the shallow crucible, which may have caused the formation of temporarily-stable 
intermediate products, which then decomposed rapidly above 550 °C, thus surpassing the values of the 
weight residues (Table S6) found in TG/DTA run already at ~600 °C and terminating at near to zero 
weight at 700 °C. It can also be postulated that the evaporation of potential oxidation products of 
phosphorus at higher temperatures occurred more easily in a shallow crucible, in turn speeding up the 
weight loss. Finally, the TG curves were essentially identical in both instruments over a temperature 
range varying from 100 to 250 °C, indicating that dehydration/deamination processes along with the 
first steps of degradation were not affected by any micro-atmospheric effects. 
Finally, melting temperatures of the compounds were evaluated from the DTA signals and were 
compared to the literature values, when available. With the anhydrous compounds, a decreasing trend 
in melting temperatures was observed in conjunction with an increase in the alkylidene chain lengths, 
as the highest melting point (223 °C) was determined for 2 and the lowest (175 °C) for 10. In the case 
of the two monohydrates, 6 and 8, the melting occurred concurrently with dehydration process that was 
observed at about 130 C for both compounds. However, it should also be noted that nearly all melting 
endotherms seen on DTA curves overlapped significantly with coexisting dehydration/deamination 
and/or decomposition transitions, inevitably conferring some degree of inaccuracy in the determination 
of the melting temperatures. 
3. Experimental 
3.1. Materials and Instrumentation 
4-Aminobutyric acid (97%), 8-aminocaprylic acid (99%), 12-aminododecanoic acid (95%),  
5-aminovaleric acid (97%), β-alanine (98%), 9-bromo-1-nonanol (95%), 10-bromodecanoic acid 
(95%), 16-bromohexadecanoic acid (>99%), phosphorus acid (99%), methanesulfonic acid (>99.5%) 
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and phosphorus trichloride (99%) were purchased from Sigma-Aldrich (Steinheim, Germany).  
6-Amino-caproic acid (>99%) and 11-aminoundecanoic acid (97%) were purchased from Acros 
Organics (Geel, Belgium). D2O (99.90% D) used in the NMR measurements was purchased from 
Euriso-Top (Gif-Sur-Yvette, France). Aqueous 0.1 M NaOH was prepared from Titrisol ampoules 
(Merck, Darmstadt, Germany) and 0.1 M HNO3 from Convol ampoules (BDH, Mumbai, India). The 
background solution was prepared by dissolving NaNO3 in deionised water. NaNO3 and NaCl used in 
reference electrode were p.a. grade (Merck). The water used in the dilutions and titration solutions was 
purified with Milli-RO and Milli-Q water purification systems (Millipore, Billerica, USA). 
Infrared spectra were recorded on a Thermo Nicolet Nexus 470 FTIR spectrometer (Thermo 
Electron Corporation, Vantaa, Finland) with the KBr pellet technique. Liquid state 1H, 13C and  
31P-NMR spectra were recorded on a Bruker Avance DRX spectrometer (Bruker, Karlsruhe, Germany) 
operating at 500.1, 125.8 and 202.5 MHz, respectively. Measurements were performed at 300 K by 
using standard pulse sequences and sodium 3-(trimethylsilyl)-1-propionic acid (TSP) was used as the 
internal standard in D2O. The solid state 13C, 15N and 31P-CPMAS NMR spectra were recorded at 300 K 
with a Bruker Avance 400 spectrometer operating at 100.62, 44.55 and 161.98 MHz, respectively. The 
spectrometer was equipped with a dual CPMAS probehead and samples were packed in 4.0 mm 
zirconia rotors. The contact times for the CPMAS experiments were 2 ms for 13C, 3 ms for 15N and  
5 ms for 31P. The relaxation delay was 5 s and the spin rate was 10 KHz. In the high-power broad 
band, 1H decoupling the pulse program was spinal64 for 13C and 15N, and tppm15 for 31P. Typically 
one hundred scans were completed for 13C and 31P, and thousands for 15N. The 13C and 15N chemical 
shifts were referenced to those of glycine (176.03 ppm for carbonyl carbon and −347.3 ppm for NH2) 
measured prior to each sample. The 31P-NMR chemical shifts are referenced to that of sodium 
alendronate measured before. All computerized spectral analysis was performed using PERCH NMR 
software, version 2010.1 (PERCH Solution Ltd, Kuopio, Finland). The starting materials for 6, 7 and 
10 were synthesized according to Amara et al. [29]. 
3.2. Synthesis 
Compounds were prepared according to the general method reported by Kieczykowski et al. [20], 
exemplified by the preparation of (4-amino-1-hydroxybutylidene)bisphosphonic acid (2; CAS Registry 
Number 66376-36-1): 4-aminobutyric acid (2.5 g, 24.2 mmol), phosphorus acid (2.0 g, 24.2 mmol) and 
methanesulfonic acid (11 mL) were put in a flask with a reflux condenser and a CaCl2-tube and the 
mixture was heated to 65 °C. PCl3 (4.3 mL, 48.4 mmol) was added dropwise and the mixture was 
maintained at 65–70 °C for 18 h (generally 16–20 h). Water (25 mL) was added to the cooled mixture 
and the solution was refluxed for 5 h. Some of the water was evaporated, EtOH was added and the 
product was allowed to crystallize at 8 °C. The product was collected by filtration and washed with 
EtOH yielding 5.1 g of 2 (85%) as white solid, yield 85%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.59 
(2H, t, J = 7.0 Hz), 1.93–1.82 (2H, m), 1.78–1.69 (2H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.3 
(t, 1JCP = 134.5 Hz), 44.6, 36.2, 30.2 (t, 2JCP = 5.0 Hz); 31P-NMR (D2O/NaOD, 202.5 MHz) δ 18.89 (s); 
IR (KBr) 3275, 2262, 1630, 1498, 1472, 1400, 1374, 1319, 1212, 1165, 1130, 1056, 994, 934, 825, 
751, 725, 665 cm−1. Anal. Calcd. for C4H13NO7P2: C, 19.29; H, 5.26; N, 5.62; P, 24.9. Found: C, 
19.19; H, 5.09; N, 5.51; P, 24.5. 
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(3-Amino-1-hydroxypropylidene)bisphosphonic acid (1; CAS Registry Number 40391-99-9). The pH 
was adjusted to 4.5 to obtain the monosodium salt, yield 22%; 1H-NMR (D2O/NaOD, 500.1 MHz) δ 
2.97–2.90 (2H, t, J = 7.8 Hz), 2.10–1.99 (2H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 78.7  
(t, 1JCP = 133.8 Hz), 40.9, 40.0 (t, 2JCP = 5.7 Hz); 31P-NMR (D2O/NaOD, 202.5 MHz): δ 18.46 (s); IR 
(KBr) 3354, 3188, 2792, 2364, 1719, 1615, 1528, 1409, 1343, 1327, 1282, 1173, 1045, 984, 937, 895, 
855, 775, 715, 683, 614 cm−1. Anal. Calcd. for C3H10NO7P2Na: C, 14.02; H, 3.92; N, 5.45; P, 24.1. 
Found: C, 14.48; H, 4.41; N, 5.64; P, 23.3. 
(5-Amino-1-hydroxypentylidene)bisphosphonic acid (3; CAS Registry Number 89732-96-7). Yield 
86%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.70 (2H, t, J = 7.0 Hz), 1.94–1.82 (2H, m), 1.66–1.57 
(2H, m), 1.51–1.43 (2H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.2 (t, 1JCP = 133.5 Hz), 42.9, 38.1, 
34.3, 24.1 (t, 2JCP = 5.3 Hz); 31P-NMR (D2O/NaOD, 202.5 MHz): δ 18.92 (s); IR (KBr) 3209, 2959, 
2331, 1617, 1503, 1468, 1452, 1219–939, 824, 663 cm−1. Anal. Calcd. for C5H15NO7P2: C, 22.82;  
H, 5.75; N, 5.32; P, 23.5. Found: C, 22.59; H, 5.82; N, 5.30; P, 23.5. 
(6-Amino-1-hydroxyhexylidene)bisphosphonic acid (4; CAS Registry Number 79778-41-9). Yield 
88%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.61 (2H, t, J = 7.0 Hz), 1.94–1.82 (2H, m), 1.62–1.53 
(2H, m), 1.51–1.43 (2H, m), 1.34–1.26 (2H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.6  
(t, 1JCP = 134.4 Hz), 43.5, 39.0, 34.7, 30.4, 26.9 (t, 2JCP = 5.2 Hz); 31P-NMR (D2O/NaOD, 202.5 MHz): 
δ 19.12 (s); IR (KBr) 3178, 2953, 2296, 1648, 1582, 1496, 1476, 1441, 1112, 1034, 997, 939, 905, 
824, 777, 724, 657 cm−1. Anal. Calcd. for C6H17NO7P2: C, 26.00; H, 6.18; N, 5.05; P, 22.4. Found: C, 
25.97; H, 6.17; N, 4.97; P, 22.2. 
(8-Amino-1-hydroxyoctylidene)bisphosphonic acid (5; CAS Registry Number: 144050-49-7). Yield 
75%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.62 (2H, t, J = 7.0 Hz), 1.93–1.81 (2H, m), 1.61–1.52 
(2H, m), 1.50–1.41 (2H, m), 1.39–1.24 (6H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 78.9  
(t, 1JCP = 132.4 Hz), 43.2, 38.4, 33.6, 33.0, 31.5, 29.0, 27.0 (t, 2JCP = 5.6 Hz); 31P-NMR (D2O/NaOD, 
202.5 MHz): δ 19.05 (s); IR (KBr) 3327, 3150, 2901, 2848, 2276, 1650, 1620, 1541, 1471, 1398, 
1334, 1300, 1224, 1151, 1079, 967, 842, 813, 767, 729, 647 cm−1. Anal. Calcd. for C8H21NO7P2: C, 
31.48; H, 6.93; N, 4.59; P, 20.3. Found: C, 31.44; H, 6.98; N, 4.69; P, 20.5. 
(9-Amino-1-hydroxynonylidene)bisphosphonic acid (6; CAS Registry Number: 144050-48-6). As an 
exception to the general method 6 was refluxed for 5 h in 2 M HCl instead of water and pH was 
adjusted to 7 to obtain the disodium salt. The product was recrystallized from water-ethanol, yield 
63%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.59 (2H, t, J = 7.0 Hz), 1.93–1.79 (2H, m), 1.59–1.50 
(2H, m), 1.50–1.38 (2H, m), 1.37–1.21 (8H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.6  
(t, 1JCP = 134.6 Hz), 43.4, 39.0, 34.7, 33.2, 31.9, 31.7, 28.9, 27.2 (t, 2JCP = 5.2 Hz); 31P-NMR 
(D2O/NaOD, 202.5 MHz): δ 19.30 (s); IR (KBr) 3195, 2910, 2850, 1637, 1558, 1475, 1168, 1040, 
906, 720, 672 cm−1. Anal. Calcd. for C9H23NO7P2 H2O: C, 32.05; H, 7.47; N, 4.15; P, 18.4. Found: C, 
31.55; H, 6.88; N, 3.92; P, 18.6. 
(10-Amino-1-hydroxydecylidene)bisphosphonic acid (7). As an exception to the general method 7 was 
refluxed for 5 h in 2 M HCl instead of water and the product was washed with water, yield 66%;  
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1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.58 (2H, t, J = 7.0 Hz), 1.93–1.80 (2H, m), 1.60–1.50 (2H, m), 
1.47–1.38 (2H, m), 1.37–1.23 (10H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.7 (t, 1JCP = 134.5 Hz), 
43.4, 39.1, 34.7, 33.3, 31.9, 31.9, 31.5, 28.9, 27.2 (t, 2JCP = 5.1 Hz); 31P-NMR (D2O/NaOD, 202.5 
MHz): δ 19.25 (s); IR (KBr) 3327, 2913, 2849, 2274, 1648, 1542, 1472, 1338, 1228, 1082, 970, 921, 
810, 772, 742, 728, 647 cm−1. Anal. Calcd. for C10H25NO7P2: C, 36.04; H, 7.56; N, 4.20; P, 18.6. 
Found: C, 35.87; H, 7.65; N, 3.94; P, 18.2. 
(11-Amino-1-hydroxyundecylidene)bisphosphonic acid (8; CAS Registry Number: 97815-71-9). Yield 
100%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.58 (2H, t, J = 7.0), 1.92–1.80 (2H, m), 1.58–1.49  
(2H, m), 1.46–1.37 (2H, m), 1.36–1.23 (12H, m); 13C-NMR (D2O/NaOD, 125.8 MHz): 79.6  
(t, 1JCP = 134.4 Hz), 43.4, 39.1, 34.6, 33.3, 31.9, 31.9, 31.6, 31.4, 28.9, 27.2 (t, 2JCP = 5.2 Hz);  
31P-NMR (D2O/NaOD, 202.5 MHz): δ 19.33 (s); IR (KBr) 3566, 3198, 2914, 2847, 2664, 2340,  
1635, 1521, 1475, 1380, 1300, 1206, 1155, 1097, 1042, 989–930, 722, 668 cm−1. Anal. Calcd. for 
C11H27NO7P2  H2O: C, 36.17; H, 8.00; N, 3.83; P, 17.0. Found: C, 36.20; H, 8.03; N, 3.73; P, 17.2. 
(12-Amino-1-hydroxydodecylidene)bisphosphonic acid (9; CAS Registry Number: 724457-78-7). The 
product was washed with hot water, yield 85%; 1H-NMR (D2O/NaOD, 500.1 MHz): δ 2.58 (2H, t,  
J = 7.0), 1.92–1.80 (2H, m), 1.58–1.49 (2H, m), 1.46–1.37 (2H, m), 1.36–1.23 (14H, m); 13C-NMR 
(D2O/NaOD, 125.8 MHz): 79.6 (t, 1JCP = 134.4 Hz), 43.4, 39.1, 34.6, 33.3, 31.9 (2C), 31.6, 31.5, 31.4, 
28.9, 27.2 (t, 2JCP = 5.2 Hz); 31P-NMR (D2O/NaOD, 202.5 MHz): δ 19.35 (s); IR (KBr) 3326, 2916, 
2849, 2360, 2342, 1647, 1542, 1472, 1333, 1227, 1067, 969, 935, 808, 773, 749, 730, 668, 648 cm−1. 
Anal. Calcd. for C12H29NO7P2: C, 39.89; H, 8.09; N, 3.88; P, 17.1. Found: C, 40.31; H, 8.18; N, 3.85; 
P, 17.0. 
(16-Amino-1-hydroxyhexadecylidene)bisphosphonic acid (10). As an exception to the general method 
10 was stirred for two days at 70 °C and refluxed over night after addition of water. The product was 
washed with methanol and hot water, yield 78%, IR 2918, 2850, 1647, 1542, 1471, 1333, 1230, 1055, 
970, 916, 804, 777, 757, 728, 667 cm−1. Anal. Calcd. for C16H37NO7P2: C, 46.04; H, 8.93; N, 3.36;  
P, 14.8. Found: C, 47.41; H, 9.08; N, 3.46; P, 14.5. 
3.3. Spectrophotometric Analysis 
A Jasco V-530 UV/Vis spectrophotometer was used for phosphorus determination at 880 nm 
wavelength. Filtered liquid samples were diluted to the appropriate volume with Milli-Q water and 
were digested with the persulphate oxidation technique in acidic medium at elevated temperature to 
convert aminobisphosponates to orthophosphate. In an acidic medium, ammonium molybdate and 
antimony potassium tartrate react with orthophosphate to form a phosphomolybdic acid that is reduced 
to intensively colored molybdenum blue by ascorbic acid [30]. 
3.4. Determination of Solubility 
Aqueous solubilities were determined at constant room temperature (21.0 °C) for compounds 1–10 
(agitation time 30 min) and at constant 4.0 °C, 7.6 °C, 21.0 °C, 30.0 °C, 40.0 °C and 50.0 °C 
temperature for compounds 2, 4 and 5 by preparing a saturated solution of the compound in Milli-Q 
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water without buffering (agitation time 24 h). The mixture containing an excess of the studied 
compound was first agitated for predetermined time with magnetic stirrer and before taking the sample 
mixture was allowed to stand for 24 h without stirring. The sample (about 5 mL) was taken from liquid 
above the solids, pH was measured and the sample was filtered through 0.2 µm membrane filter to 
remove any possible insoluble particles. The phosphorus concentration in the filtered sample solution 
was determined by using the spectrophotometric method described above. Samples for pH dependent 
solubility measurements were prepared from compounds 2, 4, 6, 8 and 9 as above, but now pH was 
adjusted to the desired value by using sodium hydroxide or hydrochloric acid solutions of the 
appropriate concentrations. 
3.5. Determination of the Protonation Constants 
The details of the experiments using (traditional) potentiometric titration are presented in the 
Supporting Information. The results of the determination by Sirius instrument are shown in the 
Supporting Information. Potentiometric titrations of the compounds were performed with the PCA200 
apparatus (Sirius Analytical Instruments Ltd, Forest Row, East Sussex, UK). 
3.6. Elemental Analysis 
Elemental analyses (C, H, N) were accomplished with a ThermoQuest CE Instruments EA  
1110-CHNS-O elemental analyzer (CE Instruments, Milan, Italy). Phosphorus contents of compounds 
were determined at 880 nm by Jasco V-530 spectrophotometer using molybdenum blue method as 
described above. Solid samples were decomposed with nitric acid by the microwave digestion 
technique using CEM MDS-81D Microwave System prior to phosphorus determination.  
3.7. Thermal Analysis 
Thermal decomposition paths with evaluation of crystal water content were obtained parallel with 
two instruments; Perkin Elmer STA 6000 thermogravimetric TG/DTA and Perkin Elmer TGA 7 
analyzers (Perkin Elmer, Massachusetts, USA). Measurements were carried out in an open platinum 
crucible (the higher 5 mm crucible was used in TG/DTA and a shallower 2 mm crucible in TGA 7) 
under air atmosphere (flow rate of 45 mL/min) with a heating rate of 5 °C/min over the temperature 
range of 25700 C. The temperature calibration of STA 6000 was made using melting points of 
indium (156.60 °C) and zinc (419.5 °C) standards. For TGA 7 magnetic Curie-point calibration 
technique (Alumel, Ni, Perkalloy, Fe) was used. The weight balance of both instruments was 
calibrated by measuring a standard weight of 50 mg at room temperature. The sample weights used in 
the measurements were about 4–8 mg, and for each bisphosphonate, it was attempted to keep the same 
on both instruments. The melting/dehydration/decomposition behavior of the compounds was also 
visually monitored using a Stuart Scientific SMP3 melting point apparatus.  
4. Conclusions  
In summary, ten aminobisphosphonates, H2N(CH2)nC(OH)[P(O)(OH)2]2 2–10 with variable chain 
lengths were prepared under similar conditions. As an exception compound 1 was isolated as a 
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monosodium salt, whereas the other compounds were crystallized in their acidic forms. The common 
physicochemical and spectroscopic data of the bisphosphonates were measured. Only compounds 6  
(n = 8) and 8 (n = 10) contained one molecule of water of crystallization. The solubility of the 
compounds was dependent on the chain length, since compounds 1–6 (n = 2–8) were soluble in gram 
per liter quantities, compound 7 in hundreds of milligrams per liter and the rest of the compounds only 
in tens of milligrams per liter. The decreasing trend in water solubility was most likely caused by the 
increasing lipophilicity of the compounds in parallel with the increase in alkyl chain length. As 
expected, temperature had also a clear effect on solubility, which was about doubled for compounds 2, 
4 and 5, when the temperature was increased from 7.6 °C to 50.0 °C. However, pH had only a minimal 
effect on solubility of compounds 2, 4 and 6, while compounds 8 and 9 displayed minimal solubility at 
pH 2. The pKa values were determined accurately for the most soluble compounds 1–5, the pKa1-pKa5 
values of which were in general 1, 2, 6, 10 and 12, respectively.  
The 1H-NMR spectra for the studied compounds were complicated due to the prochiral  
R-CH2-C(OH)P2 fragment. Detailed 1H-NMR spectral analyses were performed for compounds 1–5 
indicating that only pamidronate exhibited any remarkable intramolecular hydrogen bonding. The 
other NMR chemical shifts and coupling constants in both liquid 13C, 31P-NMR and solid state 13C, 15N 
and 31P-NMR samples were typical for these types of compounds. Thermoanalytical studies of these 
compounds revealed their relatively low thermal stability as the majority of the compounds degraded 
at about 200 C, most likely via a deamination process.  
Supplementary Materials 
Supplementary materials can be accessed at: http://www.mdpi.com/1420-3049/17/9/10928/s1. 
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